Mather Group’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.2K Hold
82
– – ﹤0.01% 1574
2026
Q2
$12K Hold
82
– – ﹤0.01% 1458
2026
Q1
$10.6K Buy
+82
New +$11.8K ﹤0.01% 1441
2025
Q4
– Sell
-82
Closed -$9.8K – 1104
2025
Q3
$9.8K Buy
+82
New +$10.4K ﹤0.01% 1273
2025
Q2
– Sell
-94
Closed -$13.1K – 1119
2025
Q1
$13.1K Buy
94
+12
+15% +$1.86K ﹤0.01% 1191
2024
Q4
$12.7K Buy
82
+75
+1,071% +$12.7K ﹤0.01% 1184
2024
Q3
$1.28K Sell
7
-18
-72% -$2.66K ﹤0.01% 1535
2024
Q2
$2.68K Sell
25
-2
-7% -$210 ﹤0.01% 1809
2024
Q1
$2.69K Buy
+27
New +$2.68K ﹤0.01% 1488

Other funds holding ICUI

Mather Group's ICUI Position: Q3 2026 in Review

Mather Group held its ICU Medical (ICUI) position steady in Q3 2026 at 82 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Mather Group first reported a position in ICUI in Q1 2024 and has held it in 9 quarters since. 43 funds tracked by Wall St. Rank hold ICUI as of Q3 2026.

  • Mather Group held 82 shares of ICU Medical worth $13.2K as of Q3 2026.
  • Mather Group left its ICU Medical share count unchanged in Q3 2026.
  • ICU Medical made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1574 holding.
  • Mather Group first reported a position in ICU Medical in Q1 2024 and has held it in 9 quarters since.
  • 43 funds tracked by Wall St. Rank held ICU Medical as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.